Bibliographic Citation
| - Valladeau‐guilemond Jenny, Bendriss‐vermare Nathalie, Chaperot Laurence . BDCA1 + cDC2s, BDCA2 + pDCs and BDCA3 + cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients . Clinical and Translational Immunology, 2020, 9 (11), ⟨10.1002/cti2.1190⟩
- Sosa Cuevas Eleonora, Ouaguia Laurissa, Mouret Stephane, Charles Julie, Fraipont Florence, Manches Olivier, Valladeau‐guilemond Jenny, Bendriss‐vermare Nathalie, Chaperot Laurence, Aspord Caroline . BDCA1 + cDC2s, BDCA2 + pDCs and BDCA3 + cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients . Clinical and Translational Immunology, 2020, 9 (11), pp.e1190 . ⟨10.1002/cti2.1190⟩
- Sosa Cuevas Eleonora, Ouaguia Laurissa, Mouret Stephane, Charles Julie, Fraipont Florence, Manches Olivier, Valladeau‐guilemond Jenny, Bendriss‐vermare Nathalie, Chaperot Laurence, Aspord Caroline. BDCA1 + cDC2s, BDCA2 + pDCs and BDCA3 + cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Clinical and Translational Immunology, 2020, 9 (11), pp.e1190. ⟨10.1002/cti2.1190⟩
|